{"url_path":"/sec/taox/10-q/2026/item-6","section_key":"item-6","section_title":"Item 6 Exhibits.","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-13","source_url":"https://www.sec.gov/Archives/edgar/data/1571934/0001104659-26-060353-index.html","accession_number":"0001104659-26-060353","cik":"0001571934","ticker":"TAOX","issuer_name":"TAO Synergies Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1571934/0001104659-26-060353-index.html","primary_entity_key":"0001571934","primary_entity_name":"TAO Synergies Inc."},"word_count":602,"has_tables":true,"body_markdown":"Item 6. Exhibits.\n\n​\n\nExhibit\nNumber\n\n  ​ ​ ​\n\n​\n\n3.1.1\n\n​\n\n[Amended and Restated Certificate of Incorporation of TAO Synergies Inc. (incorporated by reference from Exhibit 3.1 to the Registrant’s Current Report on Form 8-K filed with the SEC on December 10, 2020).](https://www.sec.gov/Archives/edgar/data/1571934/000110465920134223/tm2038220d1_ex3-1.htm)\n\n​\n\n​\n\n​\n\n3.1.2\n\n​\n\n[Certificate of Amendment to Amended and Restated Certificate of Incorporation of Synaptogenix, Inc. (incorporated by reference from Exhibit 3.1 to the Registrant’s Current Report on Form 8-K filed with the SEC on April 4, 2024).](https://www.sec.gov/Archives/edgar/data/1571934/000110465924043683/tm2411084d1_ex3-1.htm)\n\n​\n\n​\n\n​\n\n3.1.3\n\n​\n\n[Certificate of Amendment to Amended and Restated Certificate of Incorporation of Synaptogenix, Inc. (incorporated by reference from Exhibit 3.1 to the Registrant’s Current Report on Form 8-K filed with the SEC on June 27, 2025).](https://www.sec.gov/Archives/edgar/data/1571934/000110465925063601/tm2519053d1_ex3-1.htm)\n\n​\n\n​\n\n​\n\n3.2\n\n​\n\n[Amended and Restated Bylaws of TAO Synergies, Inc. (incorporated by reference from Exhibit 3.3 to the Registrant’s Quarterly Report on Form 10-Q filed with the SEC on August 14, 2025).](https://www.sec.gov/Archives/edgar/data/1571934/000141057825001820/snpx-20250630xex3d3.htm)\n\n​\n\n​\n\n​\n\n3.3\n\n​\n\n[Certificate of Designations of Series D Convertible Preferred Stock of Synaptogenix, Inc. (incorporated by reference from Exhibit 3.1 to the Registrant’s Registration Statement on Form S-3 filed with the SEC on July 11, 2025).](https://www.sec.gov/Archives/edgar/data/1571934/000110465925067442/tm2520096d1_ex3-1.htm)\n\n​\n\n​\n\n​\n\n3.4\n\n​\n\n[Certificate of Designations of Series E Convertible Preferred Stock of Synaptogenix, Inc. (incorporated by reference from Exhibit 3.1 to the Registrant’s Registration Statement on Form S-3 filed with the SEC on November 12, 2025).](https://www.sec.gov/Archives/edgar/data/1571934/000110465925110353/tm2530709d1_ex3-1.htm)\n\n​\n\n​\n\n​\n\n31.1*\n\n​\n\n[Certification of the President and Chief Executive Officer pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.](taox-20260331xex31d1.htm)\n\n​\n\n​\n\n​\n\n31.2*\n\n​\n\n[Certification of the Chief Financial Officer pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.](taox-20260331xex31d2.htm)\n\n​\n\n​\n\n​\n\n32**\n\n​\n\n[Certification of the Principal Executive Officer and Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.](taox-20260331xex32.htm)\n\n​\n\n​\n\n​\n\n101*\n\n​\n\nThe following financial information from this Quarterly Report on Form 10-Q for the period ended March 31, 2026, formatted in iXBRL (Inline Extensible Business Reporting Language): (i) the Condensed Condensed Consolidated Statements of Operations; (ii) the Condensed Condensed Consolidated Balance Sheets; (iii) the Condensed Condensed Consolidated Statements of Cash Flows; and (iv) the Notes to Financial Statements, tagged as blocks of text.\n\n​\n\n​\n\n​\n\n104*\n\n​\n\nCover Page Interactive Data File (Embedded within the Inline XBRL document and included in Exhibit)\n\n* Filed herewith.\n\n​\n\n** The certifications attached as Exhibit 32 that accompany this Quarterly Report on Form 10-Q are not deemed filed with the Securities and Exchange Commission and are not to be incorporated by reference into any filing of TAO Synergies Inc. under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of such Form 10-Q), irrespective of any general incorporation language contained in such filing.\n\n​\n\n​\n\n​\n\n​\n\n37\n\n[Table of Contents](#TOC)\n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.\n\n​\n\n \n\nTAO Synergies Inc.\n\n \n\n \n\nDate: May 13, 2026\n\nBy:\n\n/s/ Joshua N. Silverman\n\n \n\nJoshua N. Silverman\n\n \n\n \n\nExecutive Chairman of the Board of Directors\n\n \n\n \n\n(principal executive officer)\n\n \n\n \n\nDate: May 13, 2026\n\nBy:\n\n/s/ Robert Weinstein\n\n \n\n \n\nRobert Weinstein\n\n \n\n \n\nChief Financial Officer, Executive Vice President, Secretary and Treasurer\n\n​\n\n​\n\n(principal financial officer and principal accounting officer)\n\n​\n\n38"}